Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

Philip L. De Jager, Elizabeth Rossin, Saumyadipta Pyne, Pablo Tamayo, Linda Ottoboni, Vissia Viglietta, Mira Weiner, Dulce Soler, Elena Izmailova, Lauren Faron-Yowe, Carmeline O'Brien, Sam Freeman, Susana Granados, Alex Parker, Ronenn Roubenoff, Jill P. Mesirov, Samia J. Khoury, David A. Hafler, Howard L. Weiner

Research output: Contribution to journalArticle

Abstract

As part of a biomarker discovery effort in peripheral blood, we acquired an immunological profile of cell-surface markers from healthy control and untreated subjects with relapsing-remitting MS (RRMS). Fresh blood from each subject was screened ex vivo using a panel of 50 fluorescently labelled monoclonal antibodies distributed amongst 56 pools of four antibodies each. From these 56 pools, we derived an immunological profile consisting of 1018 'features' for each subject in our analysis using a systematic gating strategy. These profiles were interrogated in an analysis with a screening phase (23 patients) and an extension phase (15 patients) to identify cell populations in peripheral blood whose frequency is altered in untreated RRMS subjects. A population of CD8lowCD4- cells was identified as being reduced in frequency in untreated RRMS subjects (P = 0.0002), and this observation was confirmed in an independent sample of subjects from the Comprehensive Longitudinal Investigation of MS at the Brigham & Women's Hospital (P = 0.002). This reduction in the frequency of CD8 lowCD4- cells is also observed in 38 untreated subjects with a clinically isolated demyelination syndrome (CIS) (P = 0.0006). We also show that these differences may be due to a reduction in the CD8 lowCD56+CD3-CD4- subset of CD8 low cells, which have a natural killer cell profile. Similarities between untreated CIS and RRMS subjects extend to broader immunological profiles: consensus clustering of our data suggests that there are three distinct populations of untreated RRMS subjects and that these distinct phenotypic categories are already present in our sample of untreated CIS subjects. Thus, our large-scale immunophenotyping approach has yielded robust evidence for a reduction of CD8lowCD4- cells in both CIS and RRMS in the absence of treatment as well as suggestive evidence for the existence of immunologically distinct subsets of subjects with a demyelinating disease.

Original languageEnglish
Pages (from-to)1701-1711
Number of pages11
JournalBrain
Volume131
Issue number7
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Multiple Sclerosis
Demyelinating Diseases
Population
Immunophenotyping
Natural Killer Cells
Cluster Analysis
Biomarkers
Monoclonal Antibodies
Antibodies

Keywords

  • Cluster analysis
  • Flow cytometry
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

De Jager, P. L., Rossin, E., Pyne, S., Tamayo, P., Ottoboni, L., Viglietta, V., ... Weiner, H. L. (2008). Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain, 131(7), 1701-1711. https://doi.org/10.1093/brain/awn118

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. / De Jager, Philip L.; Rossin, Elizabeth; Pyne, Saumyadipta; Tamayo, Pablo; Ottoboni, Linda; Viglietta, Vissia; Weiner, Mira; Soler, Dulce; Izmailova, Elena; Faron-Yowe, Lauren; O'Brien, Carmeline; Freeman, Sam; Granados, Susana; Parker, Alex; Roubenoff, Ronenn; Mesirov, Jill P.; Khoury, Samia J.; Hafler, David A.; Weiner, Howard L.

In: Brain, Vol. 131, No. 7, 07.2008, p. 1701-1711.

Research output: Contribution to journalArticle

De Jager, PL, Rossin, E, Pyne, S, Tamayo, P, Ottoboni, L, Viglietta, V, Weiner, M, Soler, D, Izmailova, E, Faron-Yowe, L, O'Brien, C, Freeman, S, Granados, S, Parker, A, Roubenoff, R, Mesirov, JP, Khoury, SJ, Hafler, DA & Weiner, HL 2008, 'Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells', Brain, vol. 131, no. 7, pp. 1701-1711. https://doi.org/10.1093/brain/awn118
De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V et al. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain. 2008 Jul;131(7):1701-1711. https://doi.org/10.1093/brain/awn118
De Jager, Philip L. ; Rossin, Elizabeth ; Pyne, Saumyadipta ; Tamayo, Pablo ; Ottoboni, Linda ; Viglietta, Vissia ; Weiner, Mira ; Soler, Dulce ; Izmailova, Elena ; Faron-Yowe, Lauren ; O'Brien, Carmeline ; Freeman, Sam ; Granados, Susana ; Parker, Alex ; Roubenoff, Ronenn ; Mesirov, Jill P. ; Khoury, Samia J. ; Hafler, David A. ; Weiner, Howard L. / Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. In: Brain. 2008 ; Vol. 131, No. 7. pp. 1701-1711.
@article{04365b8e8a1c46399537d3cc921e76b8,
title = "Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells",
abstract = "As part of a biomarker discovery effort in peripheral blood, we acquired an immunological profile of cell-surface markers from healthy control and untreated subjects with relapsing-remitting MS (RRMS). Fresh blood from each subject was screened ex vivo using a panel of 50 fluorescently labelled monoclonal antibodies distributed amongst 56 pools of four antibodies each. From these 56 pools, we derived an immunological profile consisting of 1018 'features' for each subject in our analysis using a systematic gating strategy. These profiles were interrogated in an analysis with a screening phase (23 patients) and an extension phase (15 patients) to identify cell populations in peripheral blood whose frequency is altered in untreated RRMS subjects. A population of CD8lowCD4- cells was identified as being reduced in frequency in untreated RRMS subjects (P = 0.0002), and this observation was confirmed in an independent sample of subjects from the Comprehensive Longitudinal Investigation of MS at the Brigham & Women's Hospital (P = 0.002). This reduction in the frequency of CD8 lowCD4- cells is also observed in 38 untreated subjects with a clinically isolated demyelination syndrome (CIS) (P = 0.0006). We also show that these differences may be due to a reduction in the CD8 lowCD56+CD3-CD4- subset of CD8 low cells, which have a natural killer cell profile. Similarities between untreated CIS and RRMS subjects extend to broader immunological profiles: consensus clustering of our data suggests that there are three distinct populations of untreated RRMS subjects and that these distinct phenotypic categories are already present in our sample of untreated CIS subjects. Thus, our large-scale immunophenotyping approach has yielded robust evidence for a reduction of CD8lowCD4- cells in both CIS and RRMS in the absence of treatment as well as suggestive evidence for the existence of immunologically distinct subsets of subjects with a demyelinating disease.",
keywords = "Cluster analysis, Flow cytometry, Multiple sclerosis",
author = "{De Jager}, {Philip L.} and Elizabeth Rossin and Saumyadipta Pyne and Pablo Tamayo and Linda Ottoboni and Vissia Viglietta and Mira Weiner and Dulce Soler and Elena Izmailova and Lauren Faron-Yowe and Carmeline O'Brien and Sam Freeman and Susana Granados and Alex Parker and Ronenn Roubenoff and Mesirov, {Jill P.} and Khoury, {Samia J.} and Hafler, {David A.} and Weiner, {Howard L.}",
year = "2008",
month = "7",
doi = "10.1093/brain/awn118",
language = "English",
volume = "131",
pages = "1701--1711",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

AU - De Jager, Philip L.

AU - Rossin, Elizabeth

AU - Pyne, Saumyadipta

AU - Tamayo, Pablo

AU - Ottoboni, Linda

AU - Viglietta, Vissia

AU - Weiner, Mira

AU - Soler, Dulce

AU - Izmailova, Elena

AU - Faron-Yowe, Lauren

AU - O'Brien, Carmeline

AU - Freeman, Sam

AU - Granados, Susana

AU - Parker, Alex

AU - Roubenoff, Ronenn

AU - Mesirov, Jill P.

AU - Khoury, Samia J.

AU - Hafler, David A.

AU - Weiner, Howard L.

PY - 2008/7

Y1 - 2008/7

N2 - As part of a biomarker discovery effort in peripheral blood, we acquired an immunological profile of cell-surface markers from healthy control and untreated subjects with relapsing-remitting MS (RRMS). Fresh blood from each subject was screened ex vivo using a panel of 50 fluorescently labelled monoclonal antibodies distributed amongst 56 pools of four antibodies each. From these 56 pools, we derived an immunological profile consisting of 1018 'features' for each subject in our analysis using a systematic gating strategy. These profiles were interrogated in an analysis with a screening phase (23 patients) and an extension phase (15 patients) to identify cell populations in peripheral blood whose frequency is altered in untreated RRMS subjects. A population of CD8lowCD4- cells was identified as being reduced in frequency in untreated RRMS subjects (P = 0.0002), and this observation was confirmed in an independent sample of subjects from the Comprehensive Longitudinal Investigation of MS at the Brigham & Women's Hospital (P = 0.002). This reduction in the frequency of CD8 lowCD4- cells is also observed in 38 untreated subjects with a clinically isolated demyelination syndrome (CIS) (P = 0.0006). We also show that these differences may be due to a reduction in the CD8 lowCD56+CD3-CD4- subset of CD8 low cells, which have a natural killer cell profile. Similarities between untreated CIS and RRMS subjects extend to broader immunological profiles: consensus clustering of our data suggests that there are three distinct populations of untreated RRMS subjects and that these distinct phenotypic categories are already present in our sample of untreated CIS subjects. Thus, our large-scale immunophenotyping approach has yielded robust evidence for a reduction of CD8lowCD4- cells in both CIS and RRMS in the absence of treatment as well as suggestive evidence for the existence of immunologically distinct subsets of subjects with a demyelinating disease.

AB - As part of a biomarker discovery effort in peripheral blood, we acquired an immunological profile of cell-surface markers from healthy control and untreated subjects with relapsing-remitting MS (RRMS). Fresh blood from each subject was screened ex vivo using a panel of 50 fluorescently labelled monoclonal antibodies distributed amongst 56 pools of four antibodies each. From these 56 pools, we derived an immunological profile consisting of 1018 'features' for each subject in our analysis using a systematic gating strategy. These profiles were interrogated in an analysis with a screening phase (23 patients) and an extension phase (15 patients) to identify cell populations in peripheral blood whose frequency is altered in untreated RRMS subjects. A population of CD8lowCD4- cells was identified as being reduced in frequency in untreated RRMS subjects (P = 0.0002), and this observation was confirmed in an independent sample of subjects from the Comprehensive Longitudinal Investigation of MS at the Brigham & Women's Hospital (P = 0.002). This reduction in the frequency of CD8 lowCD4- cells is also observed in 38 untreated subjects with a clinically isolated demyelination syndrome (CIS) (P = 0.0006). We also show that these differences may be due to a reduction in the CD8 lowCD56+CD3-CD4- subset of CD8 low cells, which have a natural killer cell profile. Similarities between untreated CIS and RRMS subjects extend to broader immunological profiles: consensus clustering of our data suggests that there are three distinct populations of untreated RRMS subjects and that these distinct phenotypic categories are already present in our sample of untreated CIS subjects. Thus, our large-scale immunophenotyping approach has yielded robust evidence for a reduction of CD8lowCD4- cells in both CIS and RRMS in the absence of treatment as well as suggestive evidence for the existence of immunologically distinct subsets of subjects with a demyelinating disease.

KW - Cluster analysis

KW - Flow cytometry

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=46849111602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849111602&partnerID=8YFLogxK

U2 - 10.1093/brain/awn118

DO - 10.1093/brain/awn118

M3 - Article

C2 - 18567923

AN - SCOPUS:46849111602

VL - 131

SP - 1701

EP - 1711

JO - Brain

JF - Brain

SN - 0006-8950

IS - 7

ER -